After adjusting for pain intensity, a new study finds few significant differences in characteristics of chronic and subacute back pain, according to a Journal of Pain report. Some significant ...

Successful First-In-Human Use of New Parenchymal Spinal Delivery System First-ever Administration of OPC1 to a Chronic Injury Patient “Differentiated cell transplantation is a promising therapeutic ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. In China, the recommended starting dose is 30 mg/day. Patients often terminate ...

Completed enrollment in the chronic cohort and commenced enrollment in the subacute cohort of its Phase 1b/2a clinical trial for lead drug candidate, NVG-291, in spinal cord injury (SCI) Initiated an ...

Biopsychosocial self-management was associated with significant but small reductions in disability in patients with acute low back pain.

CT scan images of a female patient with a history of congential hemophilia. The red arrows in panels A and B show ASDH in the left hemisphere mimicking skull thickening. CT scan revealed complete ...